维普中文期刊产品整合服务
58篇 您的检索式:作者名="Mosca J D"
    题名 作者 年代 出处 被引量
1T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression显示文摘Elena Klyushnenkova Joseph D Mosca Valentina Zernetkina Manas K Majumdar Kirstin J Beggs Donald W Simonetti Robert J Deans Kevin R McIntosh 2005Journal of Biomedical Science2005,,1:2
2T cell responses to allogeneic human mesenchymal stem ceils: immunogenicity, tolerance, and suppression 显示文摘Klyushnenkova E Mosca J D Zernetkina V 2005Journal of biomedical science2005,12,1:1
3Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells显示文摘Majumdar M K Thiede M A Mosca J D 1998J Cell Physiol1998,176,1:1
4T cell responses to allogeneic human mesenchymal stem cells ; immunogenicity,to- lerance,and suppression显示文摘Klyushnenkova E Mosca J D Zemetkina V 2005J Biomed Sci2005,12,1:1
5Phenotypie and functional comparison of cultures of marrow-derived mesenehymal stem cells (MSCs)and stromal cells显示文摘Majumdar M K Thiede M A Mosca J D 1998J Cell Physiol1998,176,1:1
6Mesenchymal stem ceils as vehicles for gene delivery显示文摘MOSCA J D HENDRICKS J K Buyaner D 2000Clin Orthop Reiat Res2000,,:1
7Monoclonal antibodies reactive with human osteogenic cell surface antigens显示文摘Bruder S P Horowitz M C Mosca J D 1997Bone1997,21,3:1
8冠心病和其他动脉粥样硬化性血管疾病二级预防指南:2006年版(摘要)显示文摘美国心脏学会(American College of Cardiology,ACC)与美国心脏病协会(American Heart Association.AHA)关于二级预防的共识声明自2001年更新以来,许多临床试验提供了重要证据.进一步支持和拓展了对冠心病和其他动脉粥样硬化性血管疾病(包括外周动脉疾病、动脉粥样硬化性主动脉疾病和颈动脉疾病)进行积极控制危险因素治疗的重要性。证据不断涌现,证实对这些患者进行积极而全面的危险因素干预治疗能够改善生存率,减少事件复发以及对介入治疗的需要.并提高生活质量。SMITH S C ALLEN J BLAIR S N BONOW R O BRASS L M FONAROW G C GRUNDY S M HIRATZKA L JONES D KRUMHOLZ H M MOSCA L PASTERNAK R C PEARSON T PFEFFER M A TAUBERT K A 2008岭南心血管病杂志2008,14,2:1
9Multilineage potential of adult human mesenchymal stem cells显示文摘Pittenger M F Mackay A M Beck S C Jaiswal R K Douglas R Mosca J D 1999Science1999,284,:1
10Multilineage potential of adult human mesenchymal stem cells显示文摘Pittenger M F Mackay A M Beck S C Jaiswal R K Douglas R Mosca J D 1999Science1999,284,:1
11Multilineage potential of adult human mesenchymal stem cells显示文摘PITTENGER M MACKAY A BECK S JAISWAL R DOUGLAS R MOSCA J MOORMAN M SIMONETTI D CRAIG S MARSHAK D 1999Science1999,284,5411:1
12Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells(MSCs)and stromal cells显示文摘MAJUNDAR M K THIEDE M A MOSCA J D 1998J Cell Physiol1998,176,1:1
13Phenotypic and functionalcomparison of cultures of marrow derived mesenchymal stem cells(MSCs)and stromal cell显示文摘Majumdar M K Thiede M A Mosca J D 1998Cell Physiol1998,176,1:1
14Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells(MSCs) and stromal cells 显示文摘Majumdar M K Thiede M A Mosca J D 1998J Cell Physiol1998,176,1:1
15Human mesenchymal stem cells suppress allergenic T cell responses in vitro:implications for allergenic transplantation显示文摘Klyushnenkova E Mosca J D Molntosh K R 1998Blood1998,92,:1
16Phenotypic and functional comparision of cultures of marrow-derived mesenchymal stem cells(MSCs) and stromal cells显示文摘MAJUMDAR M K THIEDE M A MOSCA J D 1998Cell Physiol1998,176,1:1
17Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells(MSCs) and stromal cells显示文摘Majumdar M K Thiede M A Mosca J D 1998J cell physlol1998,176,:1
18Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem ceils (MSCs) and stromal cells 显示文摘Majumdar M K Thiede M A Mosca J D 1998J Cell Physiol1998,176,1:1
19Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells显示文摘Majumdar M K Thiede M A Mosca J D 1998J Cell Physiol1998,176,1:1
20Inhibition of HIV replication by sense and antisense RNA response elements in HIV-based retroviral vectors 显示文摘Kim J H McLinden R J Mosca J D 1996Acquir Immune Defic Syndr Hum Retroviral1996,12,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费